Literature DB >> 15474181

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Finland.

A-M Kerttula1, O Lyytikäinen, S Salmenlinna, J Vuopio-Varkila.   

Abstract

Data on methicillin-resistant Staphylococcus aureus (MRSA) cases notified to the National Infectious Disease Register (NIDR) and antibiotic resistance profiles of MRSA isolates sent to the national reference laboratory between 1997 and 2002 were analysed. In addition, the diagnostic methods used for MRSA identification in Finnish microbiology laboratories, the number of MRSA screening specimens studied, and the MRSA situation in long-term care facilities in 2001 were reviewed. MRSA cases notified to the NIDR rose from 120 in 1997 to 597 in 2002 (from 2.3 to 11.5 cases per 100,000 population). The increase was greatest in elderly people and outside Helsinki metropolitan area, in the districts where the proportion of non-multiresistant strains was most prominent. The National Committee for Clinical Laboratory Standard's guidelines for the oxacillin disk diffusion test were followed, except for the incubation temperature and time, which may have hindered detection of some MRSA strains. There was a wide geographic variation in the rates of MRSA, but this was not related to screening activity. MRSA isolates from long-term facilities accounted for more than half of the notifications to the NIDR in 2001.

Entities:  

Mesh:

Year:  2004        PMID: 15474181     DOI: 10.1016/j.jhin.2004.05.019

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  11 in total

1.  Outbreak analysis and typing of MRSA isolates by automated repetitive-sequence-based PCR in a region with multiple strain types causing epidemics.

Authors:  J J Hirvonen; T Pasanen; P Tissari; S Salmenlinna; J Vuopio; S-S Kaukoranta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-27       Impact factor: 3.267

2.  Comparison of genotypes of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in Finland.

Authors:  S Ibrahem; S Salmenlinna; A-M Kerttula; A Virolainen-Julkunen; P Kuusela; J Vuopio-Varkila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

3.  MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood.

Authors:  B Schweickert; I Noll; M Feig; H Claus; G Krause; E Velasco; T Eckmanns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

4.  [Positive screening for MRSA--clinical consequences?].

Authors:  M Neumaier; I Kappstein; M A Scherer
Journal:  Unfallchirurg       Date:  2006-06       Impact factor: 1.000

5.  Clonality of epidemic methicillin-resistant Staphylococcus aureus strains in Finland as defined by several molecular methods.

Authors:  A Vainio; M Kardén-Lilja; S Ibrahem; A M Kerttula; S Salmenlinna; A Virolainen; J Vuopio-Varkila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-15       Impact factor: 3.267

6.  Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000-2003, increasing incidence and regional differences.

Authors:  Mikael Stenhem; Ake Ortqvist; Håkan Ringberg; Leif Larsson; Barbro Olsson-Liljequist; Sara Haeggman; Karl Ekdahl
Journal:  BMC Infect Dis       Date:  2006-02-21       Impact factor: 3.090

7.  Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant Staphylococcus aureus infection by modulating antigen processing and presentation pathways.

Authors:  Gang Chen; Yanan Bai; Zhenzhen Li; Fei Wang; Xuelian Fan; Xin Zhou
Journal:  Theranostics       Date:  2020-05-30       Impact factor: 11.556

Review 8.  Meticillin-resistant Staphylococcus aureus.

Authors:  John M Boyce; Barry Cookson; Keryn Christiansen; Satoshi Hori; Jaana Vuopio-Varkila; Sesin Kocagöz; A Yasemin Oztop; Christina M J E Vandenbroucke-Grauls; Stephan Harbarth; Didier Pittet
Journal:  Lancet Infect Dis       Date:  2005-10       Impact factor: 25.071

9.  Nationwide trends in molecular epidemiology of methicillin-resistant Staphylococcus aureus, Finland, 1997-2004.

Authors:  Anne-Marie Kerttula; Outi Lyytikäinen; Minna Kardén-Lilja; Salha Ibrahem; Saara Salmenlinna; Anni Virolainen; Jaana Vuopio-Varkila
Journal:  BMC Infect Dis       Date:  2007-08-14       Impact factor: 3.090

10.  Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community.

Authors:  J A 'Chris' Delaney; Verena Schneider-Lindner; Paul Brassard; Samy Suissa
Journal:  BMC Med       Date:  2008-01-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.